Olema Pharmaceuticals, Inc.
OLMA
$13.59
-$0.23-1.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.26% | -9.11% | 3.58% | -44.08% | 9.47% |
| Total Depreciation and Amortization | -36.36% | 334.88% | -67.42% | 3.13% | 10.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 169.09% | 5.61% | -1.16% | 27.42% | -48.63% |
| Change in Net Operating Assets | -153.01% | -6.36% | -57.93% | 164.50% | -848.25% |
| Cash from Operations | -19.99% | -11.01% | -15.54% | 32.05% | -67.32% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.79% | -1,038.95% | -49.54% | 175.94% | 60.60% |
| Cash from Investing | 102.79% | -1,038.95% | -49.54% | 175.94% | 60.60% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -77.78% | 552,734.15% | -95.82% | 316.10% | -99.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.00% | -- | 100.00% | -46,328.57% | 99.78% |
| Cash from Financing | -78.60% | 520,758.54% | 101.63% | -1,234.23% | -99.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.44% | 175.76% | -1,039.06% | 102.06% | -185.76% |